EIP
PFE icon

Ellis Investment Partners’s Pfizer PFE Stock Holding History

Ellis Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Buy
17,062
+8,501
+99% +$222K 0.06% 192
2026
Q1 		$240K Buy
+8,561
New +$228K 0.04% 239
2024
Q4 		– Sell
-9,511
Closed -$275K – 245
2024
Q3 		$275K Sell
9,511
-402
-4% -$11.7K 0.05% 198
2024
Q2 		$277K Sell
9,913
-576
-5% -$15.9K 0.06% 184
2024
Q1 		$291K Sell
10,489
-930
-8% -$25.8K 0.06% 179
2023
Q4 		$329K Sell
11,419
-8,812
-44% -$266K 0.08% 160
2023
Q3 		$671K Sell
20,231
-1,628
-7% -$57.6K 0.17% 102
2023
Q2 		$802K Buy
21,859
+1,915
+10% +$74.5K 0.2% 96
2023
Q1 		$814K Buy
19,944
+1,286
+7% +$55.5K 0.21% 94
2022
Q4 		$956K Sell
18,658
-370
-2% -$17.7K 0.26% 87
2022
Q3 		$832K Buy
19,028
+323
+2% +$15.7K 0.23% 91
2022
Q2 		$980K Sell
18,705
-2,468
-12% -$126K 0.26% 85
2022
Q1 		$1.1M Buy
21,173
+7,362
+53% +$382K 0.26% 82
2021
Q4 		$815K Buy
13,811
+7,179
+108% +$356K 0.19% 100
2021
Q3 		$285K Sell
6,632
-137
-2% -$6.07K 0.07% 174
2021
Q2 		$265K Buy
6,769
+61
+0.9% +$2.37K 0.07% 174
2021
Q1 		$243K Sell
6,708
-14
-0.2% -$497 0.07% 176
2020
Q4 		$247K Buy
6,722
+14
+0.2% +$514 0.08% 166
2020
Q3 		$233K Buy
6,708
+223
+3% +$7.82K 0.08% 154
2020
Q2 		$207K Buy
6,485
+2,566
+65% +$87.2K 0.08% 158
2020
Q1 		$118K Sell
3,919
-1,906
-33% -$64.9K 0.06% 171
2019
Q4 		$216K Sell
5,825
-434
-7% -$15.5K 0.07% 144
2019
Q3 		$210K Sell
6,259
-661
-10% -$24K 0.08% 144
2019
Q2 		$287K Buy
6,920
+55
+0.8% +$2.18K 0.11% 130
2019
Q1 		$279K Buy
6,865
+54
+0.8% +$2.16K 0.11% 130
2018
Q4 		$282K Buy
+6,811
New +$283K 0.13% 122

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ellis Investment Partners's PFE Position: Q2 2026 in Review

Ellis Investment Partners increased its Pfizer (PFE) stake by 99% in Q2 2026, buying an estimated $222K and bringing the position to 17,062 shares worth $411K. The position accounts for 0.06% of the portfolio, ranked #192.

Ellis Investment Partners first reported a position in PFE in Q4 2018 and has held it in 26 quarters since. The position peaked at $1.1M in Q1 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ellis Investment Partners held 17,062 shares of Pfizer worth $411K as of Q2 2026.
  • Ellis Investment Partners bought 8,501 Pfizer shares in Q2 2026, an estimated $222K.
  • Pfizer made up 0.06% of Ellis Investment Partners's portfolio in Q2 2026, its #192 holding.
  • Ellis Investment Partners first reported a position in Pfizer in Q4 2018 and has held it in 26 quarters since.
  • Ellis Investment Partners's Pfizer position peaked at $1.1M in Q1 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.